Washington, D.C. 20549


Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 3, 2022 (December 31, 2021)

(Exact name of registrant as specified in its charter)
(State or other jurisdiction of
Incorporation or organization)
(Commission File Number)
(IRS Employer
Identification No.)
25587 Conifer Road, Suite 105-231
Conifer, Colorado 80433
(Address of principal executive offices, zip code)
(303) 640-3838
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a‑12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.0001 per share OBLG
Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 8.01. Other Events.

On June 30, 2021, Oblong, Inc., a Delaware corporation (the “Company”), completed a public offering of warrants to purchase 1,000,000 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at an exercise price of $4.00 per share (the “Series A Warrants”). On December 31, 2021, the Company agreed with all the holders of Series A Warrants to amend the terms of the Series A Warrants to extend the Termination Date from January 4, 2022 to January 4, 2023 (the “Warrant Amendment”). All other terms of the Series A Warrants will remain in full force and effect.

The foregoing description of the Series A Warrants is only a summary and does not purport to be complete and is qualified in its entirety by reference to the full text of the form of such warrant filed as Exhibit 4.1 to the Current Report on Form 8-K filed by the Company on June 28, 2021, and is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: January 3, 2022                    By:    /s/ Peter Holst        
Name: Peter Holst
Title: President & CEO



This Amendment (the “Amendment”) to the Series A Common Stock Purchase Warrant (the “Warrant”) issued by Oblong, Inc. (the “Company”) in favor of [________] (“Holder”) with an Initial Exercise Date of June 30, 2021 representing the right to purchase [________] shares of the Company’s Common Stock, is hereby entered into on [____], 2021 by and between the Company and Holder. Capitalized terms used in this Amendment and not otherwise defined herein shall have the meanings given to them in the Warrant.


WHEREAS, the Company and the Holder desire to amend the terms of the Warrant to extend the Termination Date of the Warrant; and

WHEREAS, Section 5(l) of the Warrant provides that the Warrant may be modified or amended only by written consent of the Company and the Holder.
NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Holder hereto agree to amend the Warrant as follows:
1)Amendment to “Termination Date”. The definition “Termination Date” in the preamble to the Warrant is hereby amended and restated in its entirety to read:
“January 4, 2023”

2)Effect. The Warrant, as amended hereby, is hereby confirmed in all respects and shall remain in full force and effect pursuant to the terms thereof.
(a)    Entire Agreement. This Amendment constitutes the full and entire agreement between the parties with regard to the subjects hereof and may not be further amended or modified except in accordance with the provisions of the Warrant.

(b)    Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Amendment shall be determined in accordance with the provisions of the Purchase Agreement.

(c)    Counterparts; Signatures. This Amendment may be executed in any number of counterparts each of which will be deemed an original but all of which shall be deemed one and the same document. All signatures hereto may be transmitted by facsimile or scanned email, and such facsimile or scanned email will, for all purposes, be deemed to be the original signature of the party whose signature it reproduces, and will be binding upon such party.

IN WITNESS WHEREOF, for good and valuable consideration, the parties have each consented to and duly executed this Amendment effective as of the date set forth above.

Oblong, Inc.

By: ________________________
Name: ______________________
Title: _______________________


By: ________________________
Name: ______________________
Title: _______________________

[Signature Page to Amendment to Series A Warrant]